Psychiatric DisorderCARP-RCTNCT07497763
A Brief Case Management Intervention to Promote Personal Recovery and Prevent Psychiatric Involuntary Readmissions.
A study testing Brief Case Management intervention and TAU in people with Psychiatric Disorder and Involuntary Psychiatric Hospitalization, run by Stéphane Morandi at 1 site in Switzerland.
Trial summary
The goal of this randomized control trial is to assess the effectiveness of a Brief Case Management (BCM) intervention aimed at promoting personal recovery and reducing the negative effects of coercion among people involuntarily admitted to a psychiatric hospital. Read more about this study
- Who is it for?
- Ages 18 to 64 years
- Conditions the study is for
- Psychiatric Disorder, Involuntary Psychiatric Hospitalization
- What is being tested?
- Brief Case Management intervention and TAU
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 262 participants
- Where
- 1 siteSwitzerland
- Study dates
- 1 Jul 2026to Dec 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 64 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- To have been involuntarily admitted by a medical doctor;
- To be aged between 18 and 64 years;
- To be domiciled in the catchment area of the Centre or West psychiatric sector of the Canton of Vaud;
Who cannot join
- Patients with an organic mental disorder (F0, ICD-10);
- Patients with intellectual disability (F7, ICD-10);
- Patients unable to provide written consent due to a lack of discernment;
- Patients unable to speak French well enough to participate in the study without the help of an interpreter.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Switzerland1 site, 1 recruiting
- Recruiting
Lausanne University Hospital
Lausanne, Canton of Vaud, 1003
Stéphane Morandi, +41 21 3140050, stephane.morandi@chuv.ch
Stéphane Morandi
About this study
Official title: A Brief Case Management Intervention to Promote Personal Recovery and Prevent Psychiatric Involuntary Readmissions: a Randomised Controlled Trial
The goal of this randomized control trial is to assess the effectiveness of a Brief Case Management (BCM) intervention aimed at promoting personal recovery and reducing the negative effects of coercion among people involuntarily admitted to a psychiatric hospital.
The main questions it aims to answer are :
Read more
- Does the Brief Case Management intervention reduce the incidence of involuntary readmission18 months after the initial involuntary hospitalisation?
- What impact does the Brief Case Management intervention have on patients' involuntary readmission 6 months after the initial involuntary hospitalisation, as well as on their personal recovery, perceived coercion, satisfaction with treatment, and on their exposure to other forms of formal and informal coercion?
Participants will be randomly assigned to either the control or the intervention group, accordingly they will be asked to take part in:
Control Group:
- Three evaluation sessions (baseline, 6 and 18 months follow-up);
Intervention Group :
- Three evaluation sessions (baseline, 6 and 18 months follow-up);
- The 5 sessions of the brief case management intervention (6th session optional).
Read the detailed description
Background: The use of coercion in psychiatry has been increasing for many years, both in Switzerland and abroad. While it is justified by the need to protect the health and safety of the concerned patients, coercion also represents an infringement of their fundamental rights. It can have negative effects on their health and care, for example, by causing post-traumatic stress disorder or leading to a breakdown in care. Having been involuntarily hospitalised in psychiatry is one of the main predictors of compulsory readmission. While numerous interventions have been proposed to limit the use of coercion, very few have been rigorously studied, and even fewer have been shown to be effective. Personal recovery involves leading a satisfying, contributory life, full of hope and meaning, despite the existence of a mental disorder and the resulting limitations. According to the WHO, services should be recovery-oriented to respect and promote human rights. To date, very little work has been done on the links between personal recovery and coercion. A brief case management intervention designed to promote the personal recovery of involuntarily hospitalised psychiatric patients has been developed in partnership with service-users. Its acceptability, feasibility and patients' satisfaction with the intervention were demonstrated in a six-month pilot phase.
Aims: The primary aim of the study is to test, by means of a randomised controlled trial, the effectiveness of the intervention in reducing involuntary readmissions incidence in a population of adult patients involuntarily hospitalised in psychiatry. The secondary aim is to assess the impact of the intervention on patients' personal recovery, perceived coercion, satisfaction with treatment, and on their exposure to other forms of formal and informal coercion.
Methods: 262 patients involuntarily hospitalised in psychiatry will be randomly assigned to either the intervention or control group. Patients in the intervention group will receive, in addition to standard care, a 5-session case management intervention starting within the first two weeks of hospitalisation and lasting a maximum of two months after discharge. During the sessions, patients will discuss their experience of coercion and its impact on their personal recovery. The intervention is designed to enable them to identify and mobilise their resources, improve their self-esteem, restore their confidence in the future and strengthen ties and collaborations with their entourage. They will also be invited to draw up a personal recovery plan. The number of involuntary readmissions at 18 months after inclusion will be measured in both groups as the primary outcome. The shorter-term impact of the intervention on the number of involuntary readmissions will also be assessed at the 6-month follow-up. Changes in personal recovery and other relevant variables, such as self-esteem, self-stigma, post-traumatic stress symptoms, satisfaction with care and exposure to other forms of formal or informal coercion, will also be measured at the 6- and 18-month follow-ups as secondary outcomes. Results will be evaluated on an Intent To Treat basis. Generalized linear models (GLMs) with a Poisson or negative binomial regression, based on overdispersion diagnostics, will be used to determine group differences. Other estimands such as treatment effect for patients who would not experience the intercurrent event will be considered as sensitivity analysis.
Expected results and impact: Promoting personal recovery of involuntarily admitted patients by helping them to develop and implement strategies that improve their mental well-being should mitigate the adverse consequences of coercion and reduce the risk of exposure to new coercive measures. This study will also provide a deeper understanding of the links between personal recovery and coercion.
- Being tested
- Brief Case Management intervention, TAU
- Keywords
- coercion, involuntary admission, personal recovery, case management, psychiatry
- Medical subject headings
- Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Brief Case Management interventionOther
The BCM intervention aims to support patients during the difficult phase of involuntary hospitalisation and reduce the impact of this short-term event on their long-term recovery process. It is provided by a nurse or social worker case manager. Developed in collaboration with people who have experienced coercion, the intervention starts during the hospital stay, at the latest two weeks after admission, and lasts for a maximum of two months after discharge. The intervention consists of five sessions, the order of which may vary according to the specific needs of the patient:
Session 1: Definition of "personal recovery" and impact of coercion on it Session 2 and 3: Elaboration of the Personal Recovery Plan (PRP) Session 4: Network meeting to discuss the PRP Session 5: Finalisation of the PRP For those who request it, an additional session can be arranged after three months to monitor progress and eventually adjust the recovery plan.
TAUOther
Standard inpatient and outpatient psychiatric care.
| Study group | Role | What they receive |
|---|---|---|
| Control Group | Active comparator | Treatment as usual (TAU): standard inpatient and outpatient psychiatric care Receives: Other: TAU |
| Intervention Group | Experimental | Brief Case Management intervention Receives: Other: Brief Case Management intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of involuntary readmission(s) (long-term)
The study's primary outcome will be the number of involuntary readmissions occurred at any hospital of the Canton of Vaud 18 months after study enrolment (T2). Data on involuntary readmissions will be extracted from the Register of Protection Measures (RMP) of the Canton of Vaud and the participants medical records.
Measured: Assessed at 18-month follow-up (T2).
Secondary outcomes (18)
Number of involuntary readmission(s) (short-term)
To assess the intervention's shorter-term effect, the number and duration of any involuntary readmission occurred at any hospital of the Canton of Vaud at the 6-month follow-up (T1) will be measured as secondary outcome. Data on involuntary readmissions will be extracted from the Register of Protection Measures (RMP) of the Canton of Vaud and the participants medical records.
Measured: Assessed at 6-month follow-up (T1).
Recovery Assessment Scale (RAS)
The French version of the Recovery Assessment Scale is a 24-item, self-report, patient-oriented outcome inventory. The instrument provides a total score of personal recovery as well as sub-scores on five specific dimensions: personal confidence and hope, willingness to ask for help, goal and success orientation, reliance on others, no domination by symptoms.
Developed through participatory action research and narrative analysis, this is to date the most wildly used tool to measure personal recovery. The RAS has shown satisfactory psychometric properties and sensitivity to change over time.
Measured: 3 time point assessment: at baseline (T0), 6-month follow-up (T1), 18-month follow-up (T2).
Empowerment Scale
The Empowerment Scale is a 28-item self-report measure assessing personal empowerment as defined by mental health service-users. A total score as well as five specific sub-scores can be calculated: self-esteem; power and powerlessness; community activism and autonomy; optimism and control over the future; righteous anger. This scale has shown excellent reliability and validity.
Measured: 3 time point assessment: at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Rosenberg Self-Esteem Scale (RSS)
The French version of the Rosenberg Self-Esteem Scale, a 10-item inventory measuring self-esteem. This self-report scale has shown satisfactory psychometric properties.
Measured: 3 time point assessment : at baseline (T0), 6-month follow-up (T1), 18-month follow-up (T2).
Paradox of Self-Stigma scale (PaSS-24)
The Paradox of Self-Stigma scale is a 24-items French-language self-report scale developed in collaboration with mental health service-users to measure self-stigma and its three related construct of stereotype endorsement, righteous anger and non-disclosure. The PASS-24 has shown good psychometric properties.
Measured: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Beck Hopelessness Scale (BHS)
The French version of the Beck Hopelessness Scale, is a self-report inventory of 20 true-false items which assess negative expectations about the future on three dimensions: feeling about the future, decrease in motivation and expectations. The BHS has shown good psychometric properties.
Measured: 3 time point assessment: at baseline (T0), 6-month follow-up (T1), and 18-month follow-up (T2).
WHOQOL-BREF Scale
The French version of the WHOQOL-BREF, a self-report scale including 26 Likert type items, measuring quality of life in four domains: physical health, psychological health, social relationships and environment. The WHOQOL-BREF has shown adequate psychometric properties.
Measured: 3 time point assessment : at baseline (T0), 6-month follow-up (T1), and 18-month follow-up (T2).
International Trauma Questionnaire (ITQ)
The French version of the International Trauma Questionnaire, is an 18-item self-report scale used to assess Post Traumatic Stress Disorder (PTSD) and Complex Post Traumatic Stress Disorder (C-PTSD) symptoms in adults. A total score can be calculated for the PTSD and DSO subscale. A C-PTSD score can also be calculated. The ITQ has shown good psychometric properties.
Measured: 3 time point assessment : at baseline (T0), 6-month follow-up (T1), 18-month follow-up (T2).
Pressures in Psychiatry Scale (P-PSY35)
The French version of the Pressures in Psychiatry Scale, is a 35-item self-report scale developed in collaboration with mental health service-users to assess level of exposure to informal coercion (inducements, persuasions, pressures, threats used to make patients accept therapeutic measures). The P-PSY scale has shown good psychometric properties, especially with an excellent reliability.
Measured: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Coercion Ladder (CL)
The French version of the Coercion Ladder is a single-item self-report instrument, asking patients to rate their experience of care on a visual analogue scale ranging from 1="minimum use of coercion" to 10="maximum use of coercion".
Measured: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month (T2).
Index of Fairness and the Index of Effectiveness
The Index of Fairness and the Index of Effectiveness will be used to assess if participants perceived the experienced treatment pressures as fair and effective.
These two self-administered inventories include four items each.
Measured: 3 time point assessment: at baseline (T0), 6-month follow-up (T1), and 18-month follow-up (T2).
Satisfaction with hospital care (ANQ)
Satisfaction with hospital care will be measured using the structured satisfaction questionnaire developed by the Swiss National Association for Quality Development in hospitals and clinics (ANQ). This six-item tool assess patients' satisfaction about quality of treatment, information and communication, medication, patient's implication and discharge preparation. The total score of global satisfaction will be computed and used for secondary analyses. Moreover, the ANQ questionnaire includes one-item subscale assessing responders' self-reported health.
Measured: 2 time point assessment : at baseline (T0) and 6-month follow-up (T1).
Brief INSPIRE Scale
The Brief INSPIRE scale, is a service user-rated measure of perceived staff support for personal recovery. The Brief INSPIRE consists of five items, one for each CHIME domain. Responders are asked to rate on a five-point Likert scale, from 0="not at all" to 4="very much", how much they feel supported by mental health professionals in each domain of their personal recovery. A total score between 0 and 100 can be computed.
Measured: 2 time point assessment : at baseline (T0) and 6-month follow-up (T1).
Type and number of other formal coercive measures
The type and number of other formal coercive measures received during the timeframe of the study (such as seclusion, restraint, and forced medication) will be extracted from the participants' medical records.
Measured: 3 time point assessment: at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Number and duration of any voluntary readmission occurred during the study
The number and duration of any voluntary readmission occured during the timeframe of the study will be extracted from the participants' medical records.
Measured: 2 time point assessment : at 6-month follow-up (T1) and 18-month follow-up (T2).
Exposure to other civil and legal measures
This structured questionnaire asks participants to indicate whether or not they have been exposed to any other civil measures (such as guardianship, authorised representative, advance directives) and penal measures. The items are presented in a dichotomous format, with a separate "yes" or "no" response for each tool.
Measured: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Use of recovery tools
This structured questionnaire asks participants to indicate whether or not they have previously used one or more recovery tools (such as Difficulties and Needs Self-Assessment Tool - ELADEB; Joint Crisis Plan - PCC; and the Recovery plan - REVIM) by selecting the corresponding response option for each instrument. The items are presented in a dichotomous format, with a separate "yes" or "no" response for each tool.
Measured: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Psychiatric follow-up within the last three months
This structured questionnaire asks participants to indicate whether or not they have received psychiatric follow-up within the past three months. For each type of follow-up, participants are asked to select either "yes" or "no" for the following providers: psychologist, psychiatrist, nurse, general practitioner, or other. If "other" is selected, participants are asked to specify the type of follow-up received.
Measured: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Mar 2026
- Study start1 Jul 2026
- Primary completionDec 2029 (estimated)
- Study completionDec 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Psychiatric DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Monocentric single-blinded randomised controlled trial
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 262 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Stéphane Morandi
- Sponsor type
- University, hospital or other
- Collaborators
- University of Lausanne
- Responsible party
- Sponsor-investigator, Stéphane Morandi, University of Lausanne Hospitals
- Investigators
- Stéphane Morandi, Principal investigator, Centre hospitalier universitaire vaudois (CHUV)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07497763
- Sponsor's protocol ID
- 2026-00250
- Other IDs
- 10.005.859
- Acronym
- CARP-RCT
- Status last verified
- Oct 2026
- First submitted
- 23 Mar 2026
- Last updated
- 21 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: We will only share anonymized sensitive human data for which there are a proper consent of the participants for Open Research data sharing in line with legal, ethical and confidentiality issues. We will ensure that shared data do not contain information that identifies, or that could be used in conjunction with other publicly available information to identify personally an individual. Sensitive human data that cannot be anonymized will be shared under restricted access.
Study at a glance
From the registry record, last updated by the sponsor on 21 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Brief Case Management Intervention to Promote Personal Recovery and Prevent Psychiatric Involuntary Readmissions: a Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT07497763
- Acronym / sponsor ID
- CARP-RCT / 2026-00250
- Keywords
- coercion, involuntary admission, personal recovery, case management, psychiatry
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 262 participants (estimated)
- Lead sponsor
- Stéphane MorandiUniversity, hospital or other
- Collaborators
- University of Lausanne
- Study start
- 1 Jul 2026 (actual)
- Primary completion
- Dec 2029 (estimated)
- Study completion
- Dec 2029 (estimated)
- First posted
- 27 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this randomized control trial is to assess the effectiveness of a Brief Case Management (BCM) intervention aimed at promoting personal recovery and reducing the negative effects of coercion among people involuntarily admitted to a psychiatric hospital.
The main questions it aims to answer are :
- Does the Brief Case Management intervention reduce the incidence of involuntary readmission18 months after the initial involuntary hospitalisation?
- What impact does the Brief Case Management intervention have on patients' involuntary readmission 6 months after the initial involuntary hospitalisation, as well as on their personal recovery, perceived coercion, satisfaction with treatment, and on their exposure to other forms of formal and informal coercion?
Participants will be randomly assigned to either the control or the intervention group, accordingly they will be asked to take part in:
Control Group:
- Three evaluation sessions (baseline, 6 and 18 months follow-up);
Intervention Group :
- Three evaluation sessions (baseline, 6 and 18 months follow-up);
- The 5 sessions of the brief case management intervention (6th session optional).
Detailed description
Background: The use of coercion in psychiatry has been increasing for many years, both in Switzerland and abroad. While it is justified by the need to protect the health and safety of the concerned patients, coercion also represents an infringement of their fundamental rights. It can have negative effects on their health and care, for example, by causing post-traumatic stress disorder or leading to a breakdown in care. Having been involuntarily hospitalised in psychiatry is one of the main predictors of compulsory readmission. While numerous interventions have been proposed to limit the use of coercion, very few have been rigorously studied, and even fewer have been shown to be effective. Personal recovery involves leading a satisfying, contributory life, full of hope and meaning, despite the existence of a mental disorder and the resulting limitations. According to the WHO, services should be recovery-oriented to respect and promote human rights. To date, very little work has been done on the links between personal recovery and coercion. A brief case management intervention designed to promote the personal recovery of involuntarily hospitalised psychiatric patients has been developed in partnership with service-users. Its acceptability, feasibility and patients' satisfaction with the intervention were demonstrated in a six-month pilot phase.
Aims: The primary aim of the study is to test, by means of a randomised controlled trial, the effectiveness of the intervention in reducing involuntary readmissions incidence in a population of adult patients involuntarily hospitalised in psychiatry. The secondary aim is to assess the impact of the intervention on patients' personal recovery, perceived coercion, satisfaction with treatment, and on their exposure to other forms of formal and informal coercion.
Methods: 262 patients involuntarily hospitalised in psychiatry will be randomly assigned to either the intervention or control group. Patients in the intervention group will receive, in addition to standard care, a 5-session case management intervention starting within the first two weeks of hospitalisation and lasting a maximum of two months after discharge. During the sessions, patients will discuss their experience of coercion and its impact on their personal recovery. The intervention is designed to enable them to identify and mobilise their resources, improve their self-esteem, restore their confidence in the future and strengthen ties and collaborations with their entourage. They will also be invited to draw up a personal recovery plan. The number of involuntary readmissions at 18 months after inclusion will be measured in both groups as the primary outcome. The shorter-term impact of the intervention on the number of involuntary readmissions will also be assessed at the 6-month follow-up. Changes in personal recovery and other relevant variables, such as self-esteem, self-stigma, post-traumatic stress symptoms, satisfaction with care and exposure to other forms of formal or informal coercion, will also be measured at the 6- and 18-month follow-ups as secondary outcomes. Results will be evaluated on an Intent To Treat basis. Generalized linear models (GLMs) with a Poisson or negative binomial regression, based on overdispersion diagnostics, will be used to determine group differences. Other estimands such as treatment effect for patients who would not experience the intercurrent event will be considered as sensitivity analysis.
Expected results and impact: Promoting personal recovery of involuntarily admitted patients by helping them to develop and implement strategies that improve their mental well-being should mitigate the adverse consequences of coercion and reduce the risk of exposure to new coercive measures. This study will also provide a deeper understanding of the links between personal recovery and coercion.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Monocentric single-blinded randomised controlled trial
| Arm | Type | Receives |
|---|---|---|
| Control Group | Active comparator | Other: TAUTreatment as usual (TAU): standard inpatient and outpatient psychiatric care |
| Intervention Group | Experimental | Other: Brief Case Management interventionBrief Case Management intervention |
Who may qualify
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- To have been involuntarily admitted by a medical doctor;
- To be aged between 18 and 64 years;
- To be domiciled in the catchment area of the Centre or West psychiatric sector of the Canton of Vaud;
Key exclusion criteria (4 listed)
- Patients with an organic mental disorder (F0, ICD-10);
- Patients with intellectual disability (F7, ICD-10);
- Patients unable to provide written consent due to a lack of discernment;
- Patients unable to speak French well enough to participate in the study without the help of an interpreter.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Brief Case Management interventionThe BCM intervention aims to support patients during the difficult phase of involuntary hospitalisation and reduce the impact of this short-term event on their long-term recovery process. It is provided by a nurse or social worker case manager. Developed in collaboration with people who have experienced coercion, the intervention starts during the hospital stay, at the latest two weeks after admission, and lasts for a maximum of two months after discharge. The intervention consists of five sessions, the order of which may vary according to the specific needs of the patient: Session 1: Definition of "personal recovery" and impact of coercion on it Session 2 and 3: Elaboration of the Personal Recovery Plan (PRP) Session 4: Network meeting to discuss the PRP Session 5: Finalisation of the PRP For those who request it, an additional session can be arranged after three months to monitor progress and eventually adjust the recovery plan. | Other | Intervention Group |
| TAUStandard inpatient and outpatient psychiatric care. | Other | Control Group |
Primary outcome
Number of involuntary readmission(s) (long-term)
Time frame: Assessed at 18-month follow-up (T2).
The study's primary outcome will be the number of involuntary readmissions occurred at any hospital of the Canton of Vaud 18 months after study enrolment (T2). Data on involuntary readmissions will be extracted from the Register of Protection Measures (RMP) of the Canton of Vaud and the participants medical records.
18 secondary outcomes
Number of involuntary readmission(s) (short-term)
Time frame: Assessed at 6-month follow-up (T1).
Recovery Assessment Scale (RAS)
Time frame: 3 time point assessment: at baseline (T0), 6-month follow-up (T1), 18-month follow-up (T2).
Empowerment Scale
Time frame: 3 time point assessment: at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Rosenberg Self-Esteem Scale (RSS)
Time frame: 3 time point assessment : at baseline (T0), 6-month follow-up (T1), 18-month follow-up (T2).
Paradox of Self-Stigma scale (PaSS-24)
Time frame: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Beck Hopelessness Scale (BHS)
Time frame: 3 time point assessment: at baseline (T0), 6-month follow-up (T1), and 18-month follow-up (T2).
WHOQOL-BREF Scale
Time frame: 3 time point assessment : at baseline (T0), 6-month follow-up (T1), and 18-month follow-up (T2).
International Trauma Questionnaire (ITQ)
Time frame: 3 time point assessment : at baseline (T0), 6-month follow-up (T1), 18-month follow-up (T2).
Pressures in Psychiatry Scale (P-PSY35)
Time frame: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Coercion Ladder (CL)
Time frame: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month (T2).
Index of Fairness and the Index of Effectiveness
Time frame: 3 time point assessment: at baseline (T0), 6-month follow-up (T1), and 18-month follow-up (T2).
Satisfaction with hospital care (ANQ)
Time frame: 2 time point assessment : at baseline (T0) and 6-month follow-up (T1).
Brief INSPIRE Scale
Time frame: 2 time point assessment : at baseline (T0) and 6-month follow-up (T1).
Type and number of other formal coercive measures
Time frame: 3 time point assessment: at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Number and duration of any voluntary readmission occurred during the study
Time frame: 2 time point assessment : at 6-month follow-up (T1) and 18-month follow-up (T2).
Exposure to other civil and legal measures
Time frame: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Use of recovery tools
Time frame: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Psychiatric follow-up within the last three months
Time frame: 3 time point assessment : at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Oct 2026.
- Individual participant dataSharing planned: Undecided. We will only share anonymized sensitive human data for which there are a proper consent of the participants for Open Research data sharing in line with legal, ethical and confidentiality issues. We will ensure that shared data do not contain information that identifies, or that could be used in conjunction with other publicly available information to identify personally an individual. Sensitive human data that cannot be anonymized will be shared under restricted access.
Related trials for Psychiatric Disorder
Recruiting
Electroacupuncture for Generalized Anxiety Disorder: Clinical Efficacy and Neuroimaging Mechanisms
Generalized Anxiety Disorder
Not yet recruiting
Virtual Reality to Advance Dementia Care and Quality of Life
Dementia, Agitation
Recruiting
Effects of Connective Tissue Massage Plus Biofeedback for Dyssynergic Defecation
Dyssynergic Defecation
RecruitingObservational study
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
Mood Disorders, Anxiety Disorders
Not yet recruitingObservational study
Phase 1: Thrive Together: A Feasibility and Acceptability Evaluation of Peer Mentoring for High Schoolers With ADHD and Their Caregivers
Attention-Deficit/Hyperactivity Disorder (ADHD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Stéphane Morandi principal investigator
Centre hospitalier universitaire vaudois (CHUV)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Brief Case Management intervention and TAU in people with Psychiatric Disorder and Involuntary Psychiatric Hospitalization, run by Stéphane Morandi at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Stephane Morandi (+41 21 3140050, stephane.morandi@chuv.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of involuntary readmission(s) (long-term) (time frame: Assessed at 18-month follow-up (T2).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026.